The rationale of using mesenchymal stem cells in patients with COVID‐19‐related acute respiratory distress syndrome: What to expect

Abstract The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐caused coronavirus disease 2019 (COVID‐19) pandemic has become a global health crisis with an extremely rapid progress resulting in thousands of patients who may develop acute respiratory distress syndrome (ARDS) requiring int...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Alp Can, Hakan Coskun
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Oxford University Press 2020-11-01
Serie:	Stem Cells Translational Medicine
Soggetti:	acute respiratory distress syndrome clinical trial COVID‐19 immunomodulation inflammatory disease mesenchymal stem cells
Accesso online:	https://doi.org/10.1002/sctm.20-0164
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!